General Information
Version
03 - Revision
Revision date
2023-10-30
Product name
C2 Control UFH 2
1.2.1 Relevant identified uses
Diagnostic reagent Kit component
Emergency telephone
+41 44 251 51 51
Icons in SDS
Company Information
company name
Pentapharm AG
e-mail address of the competent person responsible for the Safety Data Sheet
pentapharm@pentapharm.com
GHS Information
Signal word
Void
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Hazard pictograms
Void
Signal word
Void
Hazard statements
Void
2.3 Other hazards
The control reagent contains human derived blood plasma. As complete absence of infectious agents can never be assured, all materials derived from human or bovine tissue or body fluids should always be handled with care, observing the precautions recommended for bio-hazardous material. The human plasma used is tested on antibodies against HIV Type 1 and 2, Hepatitis C- virus, Treponema pallidum and Hepatitis B surface antigen. Hepatitis C was tested by PCR screen. The plasma was found to be negative.
PBT Substances
According to current knowledge, the product contains no PBT substance
vPvB Substances
According to current knowledge, the product contains no vPvB substance Determination of endocrine-disrupting properties Taking into account the current state of scientific knowledge, no data on endocrine disrupting properties of the product are available.
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 The product is not classified, according to the CLP regulation.
